Trial Profile
Clinical Trials Insight: 700032596
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2008
Price :
$35
*
At a glance
- Drugs Atiprimod (Primary)
- Indications Carcinoid tumour
- Focus Registrational; Therapeutic Use
- Sponsors Callisto Pharmaceuticals
- 16 Apr 2008 New trial record.